Education
About Us
Working with TipRanks
Follow Us
Vectus Biosystems Limited (AU:VBS)
ASX:VBS
Total Valuation
Vectus Biosystems Limited has a market cap or net worth of AU$3.20M. The enterprise value is AU$2.08M.
Market CapAU$3.20M
Enterprise ValueAU$2.08M
Share Statistics
Vectus Biosystems Limited has 53,333,332 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding53,333,332
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Vectus Biosystems Limited’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee―
Profits Per Employee―
Employee Count―
Asset Turnover―
Inventory Turnover―
Valuation Ratios
The current PE Ratio of Vectus Biosystems Limited is ―. Vectus Biosystems Limited’s PEG ratio is ―.
PE Ratio―
PS Ratio0.00
PB Ratio0.00
Price to Fair Value―
Price to FCF0.00
Price to Operating Cash Flow-2.22
PEG Ratio―
Income Statement
In the last 12 months, Vectus Biosystems Limited had revenue of 478.18K and earned -1.78M in profits. Earnings per share was -0.03.
Revenue478.18K
Gross Profit478.18K
Operating Income-1.69M
Pretax Income-1.78M
Net Income-1.78M
EBITDA-1.69M
Earnings Per Share (EPS)-0.03
Cash Flow
In the last 12 months, operating cash flow was -1.44M and capital expenditures 27.01K, giving a free cash flow of -1.41M billion.
Operating Cash Flow-1.44M
Free Cash Flow-1.41M
Free Cash Flow per Share-0.03
Dividends & Yields
Vectus Biosystems Limited pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.81
52-Week Price Change-25.00%
50-Day Moving Average0.06
200-Day Moving Average0.07
Relative Strength Index (RSI)45.95
Average Volume (3m)7.29K
Important Dates
Vectus Biosystems Limited upcoming earnings date is Feb 20, 2026, TBA (Confirmed).
Last Earnings DateAug 29, 2025
Next Earnings DateFeb 20, 2026
Ex-Dividend Date―
Financial Position
Vectus Biosystems Limited as a current ratio of ―, with Debt / Equity ratio of 0.00%
Current Ratio―
Quick Ratio―
Debt to Market Cap―
Net Debt to EBITDA―
Interest Coverage Ratio―
Taxes
In the past 12 months, Vectus Biosystems Limited has paid -461.18K in taxes.
Income Tax-461.18K
Effective Tax Rate―
Enterprise Valuation
Vectus Biosystems Limited EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
Vectus Biosystems Limited has AU$809.89K in cash and marketable securities with AU$0.00 in debt, giving a net cash position of AU$809.89K billion.
Cash & Marketable SecuritiesAU$809.89K
Total DebtAU$0.00
Net CashAU$809.89K
Net Cash Per ShareAU$0.02
Tangible Book Value Per Share―
Margins
Gross margin is 100.00%, with operating margin of ―, and net profit margin of ―.
Gross Margin100.00%
Operating Margin―
Pretax Margin―
Net Profit Margin―
EBITDA Margin―
EBIT Margin―
Analyst Forecast
The average price target for Vectus Biosystems Limited is ―, which is 11.43% higher than the current price. The consensus rating is Moderate Sell
Price Target―
Price Target Upside―
Analyst ConsensusModerate Sell
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast24.09%